Anti-Schistosomiasis Sm14-vaccine in Senegal

Clinical trial NCT05658614 · UNKNOWN

Trial details

NCT number: NCT05658614
Sponsor: Oswaldo Cruz Foundation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Schistosomiasis Mansoni Schistosomiasis Haematobium Vaccination; Infection

Start date: 2022-07-01
Primary completion: 2023-09-15
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.